Superdisintegrants Market - Global Forecast to 2021 - New Study Released

From: Fast Market Research, Inc.
Published: Sun Jun 19 2016

Superdisintegrants Market by Product (Croscarmellose Sodium, Crospovidone, Sodium Starch Glycolate, Ion Exchange Resins), Application (Tablets, Capsules), Therapeutic Area (Oncology, Neurology, Cardiology, Infectious Diseases) - Global Forecast to 2021

The global superdisintegrants market is expected to grow at a CAGR of 7.8% during the forecast period from 2016 to 2021. The market is poised to reach USD 416.5 million by 2021 from USD 286.8 million in 2016. The market is primarily driven by growing generic drugs market, growing population of geriatric and paediatric patients, and emergence of new superdisintegrants for the pharmaceutical industry.

In this report, the superdisintegrants market is segmented on the basis of product type, application, therapeutic area, and geography. On the basis of product type, the market is primarily segmented into natural superdisintegrants, synthetic superdisintegrants, and others. The synthetic superdisintegrants market is further sub-segmented into modified starch, crospovidone, modified cellulose, ion exchange resins, and calcium silicates. The modified cellulose market on the other hand is sub-segmented into croscarmellose sodium and L-HPC. On the basis of application the market is segmented into tablets and capsules. The market by therapeutic area is segmented into gastrointestinal diseases, neurological diseases, oncology, infectious diseases, cardiovascular diseases, haematological diseases, and inflammatory diseases.

Full Report Details at

In 2015, the synthetic superdisintegrants market accounted for the largest share of the superdisintegrants market. The large share of this segment is majorly attributed to widespread use of excipients such as sodium starch glycolate, and crospovidone in orally and fast disintegrating tablets. The crospovidone market is expected to grow at the highest CAGR during the forecast period, due to the rising preference of the excipient in formulations of solid oral dosage forms.

In 2015, North America accounted for the largest share of the global superdisintegrants market, followed by Europe, Asia-Pacific, and Rest of the World. Asia-Pacific is expected to be the fastest-growing region during the forecast period, due to the increasing outsourcing of excipient manufacturing to Asian countries, such as India and China.

Some key players in this market include Ashland, Inc. (U.S.), BASF SE (Germany), FMC Corporation (U.S.), JRS Pharma (Germany), DFE Pharma (Germany), Roquette (France), The Dow Chemical Company (U.S.), Asahi Kasei Corporation (Japan), Nippon Soda Co., Ltd. (Japan), and Huber Corporation (U.S.).
Reasons to Buy the Report:

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Global Non-Hematological Cancers Market to 2021 - Strong growth driven by increased uptake of low toxicity targeted treatments and versatile biologics
- Empty Capsules Market - Global Forecast to 2021
- Global Viral Infections Market to 2021 - Promising New Competitors and Expanding Treatment Population to Offset Increased Uptake of Generics
- Alzheimer's Disease Therapeutics in Major Developed Markets to 2021 - Aging Population and Improved Disease Understanding Increase Demand for Disease Modifying Agents
- Breast Cancer Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rapid Uptake of Premium Priced Biologics and Rising Incidence

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »